Antihyperlipoproteinemic 5-benzyl substituted-benzimidazoline-2-

Details Antihyperlipoproteinemic 5-benzyl substituted-benzimidazoline-2- Antihyperlipoproteinemic 5-benzyl substituted-benzimidazoline-2-

1991-09-03

1992-11-10

Morris, Patricia L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

5483071, A61L 31415, C07D23528

Patent

active

051623595

ABSTRACT:
Novel antihyperlipoproteinemic compounds are disclosed of the formula I, ##STR1## wherein X is a halogen atom, methyl, ethyl, methoxy or ethoxy group,

REFERENCES:
patent: 4814329 (1989-03-01), Harsanyi et al.

Affiliated with

Also associated with

Rating

Antihyperlipoproteinemic 5-benzyl substituted-benzimidazoline-2- does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antihyperlipoproteinemic 5-benzyl substituted-benzimidazoline-2-, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antihyperlipoproteinemic 5-benzyl substituted-benzimidazoline-2- will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2293192